Highly Challenging Balance Program to Reduce Fall Rate in PD

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Recruiting
CT.gov ID
NCT03972969
Collaborator
(none)
162
1
3
46
3.5

Study Details

Study Description

Brief Summary

This study will test the hypothesis that two highly challenging exercise programs, one based at the VA medical center and the other conducted remotely, will both significantly reduce overall fall rates in patients with Parkinson's disease.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Facility-based structured exercise
  • Behavioral: Home-based structured exercise
  • Behavioral: Health education
N/A

Detailed Description

Background/Rationale. Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting over one million Americans. The cardinal clinical manifestations of PD include resting tremor, rigidity, bradykinesia, and postural instability/gait disturbance. In addition, people with PD fall frequently, with 60% falling annually and two-thirds of these falling recurrently. Identifying interventions that successfully improve postural control and reduce fall rate is critical to reduce disability, improve quality of life, and potentially increase survival in patients with PD. Recent randomized, controlled trials (RCT) have examined the effects of exercise and physical therapy interventions on reducing falls in patients with PD; however, with mixed results.

Objectives. There is a limited availability of effective treatment options to reduce falls in PD. In this context, some studies suggest that highly challenging exercise approaches may lead to better outcomes. The investigators propose investigating the effects of two theoretically driven, progressive, highly challenging exercise programs: 1) a structured exercise program at the VA and 2) a structured exercise program at home. There will also be a control group in which health education is provided.

Methods. The investigators propose to conduct an RCT evaluating effects on fall rate. A total of 162 VA patients with mild-to-moderate PD will be randomly assigned to one of the three 3-month interventions: in-person exercise at the VA, remotely-delivered exercise, or health education. Outcomes will be compared between each intervention group and the control group. Fall rates will be compared between groups with the use of negative binomial regression models.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
162 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Highly Challenging Balance Program to Reduce Fall Rate in PD
Actual Study Start Date :
Oct 1, 2019
Anticipated Primary Completion Date :
Feb 28, 2023
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: In-person exercise group

facility-based structured exercise program

Behavioral: Facility-based structured exercise
Structured exercise program in a facility with instruction and encouragement

Experimental: Remote exercise group

home-based structured exercise program

Behavioral: Home-based structured exercise
Structured exercise program in the home with instruction and encouragement

Active Comparator: Control group

health education

Behavioral: Health education
Provision of general information about a variety of topics

Outcome Measures

Primary Outcome Measures

  1. Falls [3 months]

    Falls are defined as unexpected events in which the participants come to rest on the ground, floor, or lower level.

Secondary Outcome Measures

  1. Falls [6 months]

    Falls are defined as unexpected events in which the participants come to rest on the ground, floor, or lower level.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Physician diagnosis of idiopathic PD

  • At least 2 of the 3 cardinal signs of PD (resting tremor, rigidity, bradykinesia)

  • Response to dopaminergic medication

Exclusion Criteria:
  • Angina pectoris

  • History of myocardial infarction (MI) within 6 months

  • History of ventricular dysrhythmia requiring current therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA Boston Massachusetts United States 02130

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: David William Sparrow, DSc, VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT03972969
Other Study ID Numbers:
  • E3055-R
First Posted:
Jun 4, 2019
Last Update Posted:
Feb 10, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by VA Office of Research and Development
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2022